Halina Kwiecień

Dr. Halina Kwiecień


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2015 in Medicinal Chemistry Research
Verified
Journal Article
Open access
PDF file
AGAgata Goszczyńska
Agata Goszczyńska
HKHalina Kwiecień
Halina Kwiecień
Karol FijalkowskiKarol Fijalkowski
Karol Fijalkowski
A series of novel Schiff bases and secondary amines were obtained in good yields, as a result of the reductive amination of alkyl 2-(2-formyl-4-nitrophenoxy)alkanoates with both aniline and 4-methoxyaniline under established mild reaction conditions. Sodium triacetoxyborohydride as well as hydrogen in the presence of palladium on carbon were used as efficient reducing agents of the Schiff bases, in both direct and stepwise reductive amination processes. The Schiff bases, amines, and amine hydrochlorides were designed as potential antibacterial agents, and structure–activity relationship could be established following in vitro assays against Gram-positive and Gram-negative bacteria. The minimal inhibitory concentration and zone of inhibition were also determined. In these tests, some of Schiff bases and secondary amine hydrochlorides showed moderate-to-good activity against Gram-positive bacteria, including S. aureus, M. luteus, and S. mutans.

1 July 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
HKHalina Kwiecień
Halina Kwiecień
MPMagdalena Perużyńska
Magdalena Perużyńska
KSKarolina Stachowicz
Karolina Stachowicz
KPKatarzyna Piotrowska
Katarzyna Piotrowska
JBJoanna Bujak
Joanna Bujak
Marek DrozdzikMarek Drozdzik
Marek Drozdzik

10 March 2016 in Journal of Environmental Science and Health, Part B
Verified
Journal Article
Closed access
MŚMałgorzata Śmist
Małgorzata Śmist
HKHalina Kwiecień
Halina Kwiecień
MKMaria Krawczyk
Maria Krawczyk
A series of 2-alkyl-2H-1,4-benzoxazin-3(4H)-ones (4a-l) was easily synthesized by two-step process involving O-alkylation of 2-nitrophenols with methyl 2-bromoalkanoates and next “green” catalytic reductive cyclization of the obtained 2-nitro ester intermediates (3a-l). Further, 6,7-dibromo (5a-c) and N-acetyl (6) derivatives were prepared by bromination and acetylation of unsubstituted 2-alkyl-2H-1,4-benzoxazin-3(4H)-ones (4a-c). The novel compounds (3a-l, 4d-l, 5a-c and 6) were fully characterized by spectroscopic methods (MS, 1H and 13C NMR). 2-Alkyl-2H-1,4-benzoxazin-3(4H)-ones (4a-l, 5a-c and 6) were screened for antifungal activity. Preliminary assays were performed using two methods: in vitro against seven phytopathogenic fungi—Botrytis cinerea, Phythophtora cactorum, Rhizoctonia solani, Phoma betae, Fusarium culmorum, Fusarium oxysporum and Alternaria alternata—and in vivo against barley powdery mildew Blumeria graminis. The tested compounds displayed moderate to good antifungal activity at high concentration (200 mg L−1). The most potent compounds were 2-ethyl-2H-1,4-benzoxazin-3(4H)-one (4a), 2-ethyl-7-fluoro-2H-1,4-benzoxazin-3(4H)-one (4g) and 4-acetyl-2-ethyl-2H-1,4-benzoxazin-3(4H)-one (6), which completely inhibited the mycelial growth of seven agricultural fungi at the concentration of 200 mg L−1 in the in vitro tests. Moreover, 2-ethyl-2H-1,4-benzoxazin-3(4H)-one (4a) and 4-acetyl-2-ethyl-2H-1,4-benzoxazin-3(4H)-one (6) were also screened for antifungal activity at concentrations of 100 mg L−1 and 20 mg L−1. In the concentration of 100 mg L−1, the N-acetyl derivative (6) completely inhibited the growth of three strains of fungi (F. culmorum, P. cactorum and R. solani), while 2-ethyl-2H-1,4-benzoxazin-3(4H)-one (4a) completely inhibited only R. solani strain. At the concentration of 20 mg L−1, compound 6 showed good activity only against P. cactorum strain (72%).

27 January 2016 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
HKHalina Kwiecień
Halina Kwiecień
AGAgata Goszczy
Agata Goszczy
Kinases are known to regulate the majority of human cellular processes such as communication, division, metabolism, survival and apoptosis therefore they can be promising targets in cancer diseases, viral infection and in other disorders. Small molecules acting as selective human protein kinase inhibitors are very attractive pharmacological targets. This review presents a number of examples of biologically active natural and synthetic benzo[b]furans and their derivatives, such as benzo[b]furan-2- and 3-ones, benzo[b]furan-2- and 3-carboxylic acids, as well as benzo[c]furans as potential inhibitors of various human protein kinases. The pathways of function and implication of the inhibitors in cancer and other diseases are discussed.

14 October 2019
Verified
Book Chapter
Closed access
HKHalina Kwiecień
Halina Kwiecień
AWAlicja Wodnicka
Alicja Wodnicka

17 October 2012 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
MKM. Kowalewska
M. Kowalewska
HKHalina Kwiecień
Halina Kwiecień
MŚM. Śmist
M. Śmist
AWA. Wrześniewska
A. Wrześniewska
Novel ethyl ester and methylamide of 5‐[bis(2‐chloroethyl)amino]‐7‐methoxybenzofuran‐2‐carboxylic acid as well as (2‐hydroxy‐1,1‐dimethylethyl)amides of 5‐bromo‐ and 5,7‐dichlorobenzofuran‐2‐carboxylic acid were synthesized and characterized.